Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma

Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers. To date, most patients with HCC are diagnosed at an advanced tumor stage, excluding them from potentially curative therapies (i.e., resection, liver transplantation, percutaneous ablation). Treatments with palliative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: De Mattia, Elena, Cecchin, Erika, Guardascione, Michela, Foltran, Luisa, Di Raimo, Tania, Angelini, Francesco, D’Andrea, Mario, Toffoli, Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689804/
https://ncbi.nlm.nih.gov/pubmed/31413525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i29.3870
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars